↓ Skip to main content

Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial

Overview of attention for article published in The Lancet, December 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial
Published in
The Lancet, December 2014
DOI 10.1016/s0140-6736(14)60841-2
Pubmed ID
Authors

Asha C Bowen, Steven Y C Tong, Ross M Andrews, Irene M O'Meara, Malcolm I McDonald, Mark D Chatfield, Bart J Currie, Jonathan R Carapetis

Twitter Demographics

The data shown below were collected from the profiles of 18 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 3%
Australia 2 3%
Unknown 63 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 24%
Other 13 19%
Student > Ph. D. Student 8 12%
Student > Master 7 10%
Unspecified 7 10%
Other 16 24%
Readers by discipline Count As %
Medicine and Dentistry 36 54%
Unspecified 11 16%
Agricultural and Biological Sciences 4 6%
Biochemistry, Genetics and Molecular Biology 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 10 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 58. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2019.
All research outputs
#295,583
of 13,503,031 outputs
Outputs from The Lancet
#3,388
of 31,955 outputs
Outputs of similar age
#5,137
of 199,601 outputs
Outputs of similar age from The Lancet
#88
of 481 outputs
Altmetric has tracked 13,503,031 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,955 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.9. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 199,601 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 481 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.